Secukinumab
| CAS No. | 875356-43-7/1229022-83-6 | Cat. No. | BCP26257 |
| Name | Secukinumab | ||
| Synonyms | AIN457；AIN 457；AIN-457; | ||
| Formula | C6584H10134N1754O2042S44 | M. Wt | 147.94 kg/mol |
| Description | Secukinumab inhibits a member of the cytokine family, interleukin 17A, which is produced mainly by inflammatory T helper 17 cells.IL17A is upregulated in serum of people with psoriasis and in the synovial fluid of people with psoriatic arthritis, and promotes inflammation when it binds to the interleukin-17 receptor which is expressed in various types of cells, including keratinocytes in skin. | ||
| Pathways | Others Pathway | ||
| Targets | Interleukin Related | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.